Viewing Study NCT00361959


Ignite Creation Date: 2025-12-24 @ 2:52 PM
Ignite Modification Date: 2025-12-25 @ 6:06 PM
Study NCT ID: NCT00361959
Status: COMPLETED
Last Update Posted: 2017-01-20
First Post: 2006-08-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: SERETIDE 50/500mcg Versus Tiotropium Bromide On Exacerbation Rates In Severe Chronic Obstructive Pulmonary Disease
Sponsor: GlaxoSmithKline
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module